Related Experiment Video

Updated: Aug 19, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs

Edward Kyu-Ho Han1, Thomas Mcgonigal, Jieyi Wang

  • 1Abbott Laboratories, Global Pharmaceutical Research Division, Cancer Division, 100 Abbott Park Rd, Abbott Park, IL 60064, USA. edward.k.han@abbott.com

Anticancer Research
|March 2, 2005
PubMed

Insights

Inhibition of focal adhesion kinase (FAK) in cancer cells reduced colony formation and migration. This study explored FAK

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase found at cell-extracellular matrix adhesion sites.
  • FAK plays roles in cell invasion, motility, proliferation, and apoptosis.
  • Elevated FAK expression is observed in various human cancers, indicating its potential role in malignancy.

Purpose of the Study:

  • To investigate the biological functions of FAK in cancer cells.
  • To assess the impact of FAK inhibition on cancer cell growth, colony formation, and migration.

Main Methods:

  • Utilized small inhibitory RNAs (siRNA) to reduce FAK protein levels in cancer cell lines.
  • Quantified FAK protein reduction via Western blotting (approximately 70% reduction).
  • Assessed effects on apoptosis, clonogenic and soft-agar colony formation, and cell migration using serum or EGF as chemo-attractants.

Main Results:

  • FAK siRNA treatment significantly reduced FAK protein levels but did not induce clear apoptosis.
  • A 43% to 55% decrease in colony formation was observed in H1299 lung cancer cells.
  • FAK inhibition led to reduced cell migration in response to serum or epidermal growth factor (EGF).

Conclusions:

  • Inhibition of FAK protein impacts cancer cell growth and migration.
  • Targeting FAK may represent a therapeutic strategy for reducing cancer cell proliferation and metastasis.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...